It was shown that epigenetic inactivation of EXT1, leading to an abrogation of HS biosynthesis, is common for leukemia and non-melanoma skin cancer, and reintroduction of EXT1 into HS-deficient leukemia cells HL-60 suppressed colony formation and growth of tumour xenografts [20]. The gene discussed is EXT1; the disease is leukemia.